logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Amira Pharmaceuticals, Inc.


USPTO Granted Patents = 23

% Expired Patents = 21.7


Forward Citations = 236

Loading Chart...
Loading Chart...

27 inventors (with patents filed for the assignee):

goldMedal John Howard Hutchinson (18 out of 112 patents)

silverMedal Thomas Jon Seiders (15 out of 31 patents)

bronzeMedal Jeannie M Arruda (12 out of 28 patents)

4.  Nicholas Simon Stock (11 out of 37 patents)

5.  Jeffrey Roger Roppe (10 out of 29 patents)

6.  Deborah Volkots (9 out of 13 patents)

7.  Brian Andrew Stearns (8 out of 36 patents)

8.  Timothy Andrew Parr (8 out of 12 patents)

9.  Bowei Wang (8 out of 26 patents)

10.  Lucy Xiumin Zhao (6 out of 20 patents)

11.  Ryan Christopher Clark (5 out of 18 patents)

12.  Jill Melissa Scott (4 out of 9 patents)

13.  Yen Truong (3 out of 17 patents)

14.  Heather Renee Coate (3 out of 32 patents)

15.  Jillian Frances Evans (2 out of 9 patents)


23 patents:

1. 10000456 - Polycyclic compounds as lysophosphatidic acid receptor antagonists (2018-06-19),
2. 9849109 - Autotaxin inhibitors and uses thereof (2017-12-26),
3. 9624182 - Compounds as lysophosphatidic acid receptor antagonists (2017-04-18),
4. 9556133 - Polycyclic LPA1 antagonist and uses thereof (2017-01-31),
5. 9272990 - Lysophosphatidic acid receptor antagonists and their use in the treatment fibrosis (2016-03-01),
6. 9260416 - Heterocyclic autotaxin inhibitors and uses thereof (2016-02-16),
7. 9090573 - Compounds as lysophosphatidic acid receptor antagonists (2015-07-28),
8. 9000025 - Autotaxin inhibitors and uses thereof (2015-04-07),
9. 8778983 - Polycyclic compounds as lysophosphatidic acid receptor antagonists (2014-07-15),
10. 8664220 - Polycyclic compounds as lysophosphatidic acid receptor antagonists (2014-03-04),
11. 8592402 - Compounds as lysophosphatidic acid receptor antagonists (2013-11-26),
12. 8541587 - Lysophosphatidic acid receptor antagonists (2013-09-24),
13. 8455499 - Alkyne antagonists of lysophosphatidic acid receptors (2013-06-04),
14. 8440707 - Antagonists of lysophosphatidic acid receptors (2013-05-14),
15. 8273780 - Polycyclic antagonists of lysophosphatidic acid receptors (2012-09-25),
Company Overview
Amira Pharmaceuticals, Inc. is a biotechnology company based in Princeton, NJ, specializing in the discovery and development of innovative therapeutics for various diseases. The organization focuses on advancing small molecule drugs that target specific biological pathways, particularly in the fields of oncology and inflammation. With a commitment to scientific excellence, Amira leverages cutting-edge research and technology to address unmet medical needs and improve patient outcomes.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

23 Patents

#42 in Princeton, NJ

#558 in New Jersey

#14,415 in US

#27,649 in the World

Princeton, NJ (US)
Princeton, NJ, United States of America

Amira Pharmaceuticals, Inc.

Forward Citations = 236

27 inventors:

goldMedal John Howard Hutchinson (18 out of 112 patents)

silverMedal Thomas Jon Seiders (15 out of 31 patents)

bronzeMedal Jeannie M Arruda (12 out of 28 patents)

4.  Nicholas Simon Stock (11 out of 37 patents)

5.  Jeffrey Roger Roppe (10 out of 29 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Amira Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/amira-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…